[Gly14]-Humanin improved the learning and memory impairment induced by scopolamine in vivo

被引:104
作者
Mamiya, T [1 ]
Ukai, M [1 ]
机构
[1] Meijo Univ, Fac Pharmaceut Sci, Dept Chem Pharmacol, Tempaku Ku, Nagoya, Aichi 4688503, Japan
关键词
humanin; Gly(14)]-humanin; Alzheimer's disease; learning and memory; Y-maze test;
D O I
10.1038/sj.bjp.0704429
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Humanin is a very recently discovered 24 amino acid linear polypeptide, which protects against cell death induced by either familial Alzheimer's disease mutant of amyloid precursor protein, presenilin-1 or presenilin-2 in vitro. However, it has remained uncertain whether humanin is a useful drug for the animal model of learning and memory deficit. In this study. we evaluated the effects of [Gly(14)]-humanin, a more potent humanin analogue, on the scopolamine HBr (1 mg kg(-1) s.c.)-induced impairment of spontaneous alternation behaviour in the Y-maze, an index of short-term memory in mice. [Gly(14)]-Humanin (1000 pmol 5 mul(-1) i.c.v.) reversed the impairment without affecting the number of arm entries. These results suggest that (I) [Gly(14)]-humanin is a beneficial drug for the impairment of learning and memory and (II) it modulates the learning and memory function mediated via cholinergic systems in mice.
引用
收藏
页码:1597 / 1599
页数:3
相关论文
共 12 条
[1]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[2]   A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ [J].
Hashimoto, Y ;
Niikura, T ;
Tajima, H ;
Yasukawa, T ;
Sudo, H ;
Ito, Y ;
Kita, Y ;
Kawasumi, M ;
Kouyama, K ;
Doyu, M ;
Sobue, G ;
Koide, T ;
Tsuji, S ;
Lang, JC ;
Kurokawa, K ;
Nishimoto, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) :6336-6341
[3]   Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein [J].
Hashimoto, Y ;
Ito, Y ;
Niikura, T ;
Shao, Z ;
Hata, M ;
Oyama, F ;
Nishimoto, I .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (02) :460-468
[4]   Nociceptin orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice [J].
Hiramatsu, M ;
Inoue, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (03) :655-660
[5]   Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous κ-opioid receptor agonist [J].
Hiramatsu, M ;
Murasawa, H ;
Mori, H ;
Kameyama, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (05) :920-926
[6]  
KOVACS GL, 1994, PHARMACOL REV, V46, P269
[7]   Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice [J].
Mamiya, T ;
Noda, Y ;
Noda, A ;
Hiramatsu, M ;
Karasawa, K ;
Kameyama, T ;
Furukawa, S ;
Yamada, K ;
Nabeshima, T .
NEUROPHARMACOLOGY, 2000, 39 (12) :2391-2398
[8]   SA4503, a novel cognitive enhancer with sigma(1) receptor agonist properties, facilitates NMDA receptor-dependent learning in mice [J].
Maurice, T ;
Privat, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 328 (01) :9-18
[9]  
Newhouse P A, 1990, Adv Exp Med Biol, V282, P65
[10]   ATTENUATION OF SCOPOLAMINE-INDUCED IMPAIRMENT OF SPONTANEOUS-ALTERNATION BEHAVIOR BY ANTAGONIST BUT NOT INVERSE AGONIST AND AGONIST BETA-CARBOLINES [J].
SARTER, M ;
BODEWITZ, G ;
STEPHENS, DN .
PSYCHOPHARMACOLOGY, 1988, 94 (04) :491-495